These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32545609)

  • 61. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.
    Kordower JH; Olanow CW; Dodiya HB; Chu Y; Beach TG; Adler CH; Halliday GM; Bartus RT
    Brain; 2013 Aug; 136(Pt 8):2419-31. PubMed ID: 23884810
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
    Schwarz ST; Afzal M; Morgan PS; Bajaj N; Gowland PA; Auer DP
    PLoS One; 2014; 9(4):e93814. PubMed ID: 24710392
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Automatic classification of dopamine transporter SPECT: deep convolutional neural networks can be trained to be robust with respect to variable image characteristics.
    Wenzel M; Milletari F; Krüger J; Lange C; Schenk M; Apostolova I; Klutmann S; Ehrenburg M; Buchert R
    Eur J Nucl Med Mol Imaging; 2019 Dec; 46(13):2800-2811. PubMed ID: 31473800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3
    Schwarz ST; Xing Y; Naidu S; Birchall J; Skelly R; Perkins A; Evans J; Sare G; Martin-Bastida A; Bajaj N; Gowland P; Piccini P; Auer DP
    BMJ Open; 2017 Dec; 7(12):e016904. PubMed ID: 29247084
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
    Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
    Nalls MA; McLean CY; Rick J; Eberly S; Hutten SJ; Gwinn K; Sutherland M; Martinez M; Heutink P; Williams NM; Hardy J; Gasser T; Brice A; Price TR; Nicolas A; Keller MF; Molony C; Gibbs JR; Chen-Plotkin A; Suh E; Letson C; Fiandaca MS; Mapstone M; Federoff HJ; Noyce AJ; Morris H; Van Deerlin VM; Weintraub D; Zabetian C; Hernandez DG; Lesage S; Mullins M; Conley ED; Northover CA; Frasier M; Marek K; Day-Williams AG; Stone DJ; Ioannidis JP; Singleton AB;
    Lancet Neurol; 2015 Oct; 14(10):1002-9. PubMed ID: 26271532
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.
    Castellanos G; Fernández-Seara MA; Lorenzo-Betancor O; Ortega-Cubero S; Puigvert M; Uranga J; Vidorreta M; Irigoyen J; Lorenzo E; Muñoz-Barrutia A; Ortiz-de-Solorzano C; Pastor P; Pastor MA
    Mov Disord; 2015 Jun; 30(7):945-52. PubMed ID: 25772492
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease.
    Wang J; Huang Z; Li Y; Ye F; Wang C; Zhang Y; Cheng X; Fei G; Liu K; Zeng M; Zhong C; Jin L
    Parkinsonism Relat Disord; 2019 Jan; 58():3-8. PubMed ID: 30037690
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Changed firing activity of nigra dopaminergic neurons in Parkinson's disease.
    Chen XY; Liu C; Xue Y; Chen L
    Neurochem Int; 2023 Jan; 162():105465. PubMed ID: 36563966
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease.
    Du G; Lewis MM; Styner M; Shaffer ML; Sen S; Yang QX; Huang X
    Mov Disord; 2011 Aug; 26(9):1627-32. PubMed ID: 21618607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Deep learning approaches using 2D and 3D convolutional neural networks for generating male pelvic synthetic computed tomography from magnetic resonance imaging.
    Fu J; Yang Y; Singhrao K; Ruan D; Chu FI; Low DA; Lewis JH
    Med Phys; 2019 Sep; 46(9):3788-3798. PubMed ID: 31220353
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson's disease with freezing of gait.
    Wang S; Wu T; Cai Y; Yu Y; Chen X; Wang L
    Front Aging Neurosci; 2023; 15():1060935. PubMed ID: 36819729
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor Diagnosis against Other Brain Diseases Using T2 MRI Brain Images and CNN Binary Classifier and DWT.
    Papadomanolakis TN; Sergaki ES; Polydorou AA; Krasoudakis AG; Makris-Tsalikis GN; Polydorou AA; Afentakis NM; Athanasiou SA; Vardiambasis IO; Zervakis ME
    Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microstructural abnormalities of substantia nigra in Parkinson's disease: A neuromelanin sensitive MRI atlas based study.
    Safai A; Prasad S; Chougule T; Saini J; Pal PK; Ingalhalikar M
    Hum Brain Mapp; 2020 Apr; 41(5):1323-1333. PubMed ID: 31778276
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
    Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
    J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Deep Convolutional Neural Network With Performance Comparable to Radiologists for Differentiating Between Spinal Schwannoma and Meningioma.
    Maki S; Furuya T; Horikoshi T; Yokota H; Mori Y; Ota J; Kawasaki Y; Miyamoto T; Norimoto M; Okimatsu S; Shiga Y; Inage K; Orita S; Takahashi H; Suyari H; Uno T; Ohtori S
    Spine (Phila Pa 1976); 2020 May; 45(10):694-700. PubMed ID: 31809468
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emotion processing in Parkinson's disease: a blood oxygenation level-dependent functional magnetic resonance imaging study.
    Benzagmout M; Boujraf S; Alami B; Amadou HA; El Hamdaoui H; Bennani A; Jaafari M; Rammouz I; Maaroufi M; Magoul R; Boussaoud D
    Neural Regen Res; 2019 Apr; 14(4):666-672. PubMed ID: 30632507
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Progression marker of Parkinson's disease: a 4-year multi-site imaging study.
    Burciu RG; Ofori E; Archer DB; Wu SS; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Brain; 2017 Aug; 140(8):2183-2192. PubMed ID: 28899020
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker.
    Gaurav R; Yahia-Cherif L; Pyatigorskaya N; Mangone G; Biondetti E; Valabrègue R; Ewenczyk C; Hutchison RM; Cedarbaum JM; Corvol JC; Vidailhet M; Lehéricy S
    Mov Disord; 2021 Jul; 36(7):1592-1602. PubMed ID: 33751655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.